Absolutely Haplo, these world leading surgeons know that CardioCel is the future and arent afraid to say it......
Olivier Ghez is a massive addition to the surgeons currently supporting and using CardioCel and his experiences and recommendation of the technology will carry far and wide over the global field of paediatric cardiac surgery influencing many others, and not just at his hospital, to investigate and use the technology also. Olivier Ghez is an opinion maker in this regard and is proof that Admedus has many KOLs onside in their battle to gain market share.
Ann: Admedus to showcase CardioCel at EACTS Annual Meeting, page-17
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.090(0.50%) |
Mkt cap ! $344.2M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.00 | $18.00 | $4.374K | 243 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 681 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.22 | 11 | 1 |
View Market Depth
| Last trade - 09.59am 16/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |